160 related articles for article (PubMed ID: 30526175)
1. Anaplastic oligodendroglioma metastasizing to the bone marrow: a unique case report and literature review.
Singh VK; Singh S; Bhupalam L
Int J Neurosci; 2019 Jul; 129(7):722-728. PubMed ID: 30526175
[TBL] [Abstract][Full Text] [Related]
2. Bone Marrow Metastases from a 1p/19q Co-deleted Oligodendroglioma - A Case Report.
Demeulenaere M; Duerinck J; DU Four S; Fostier K; Michotte A; Neyns B
Anticancer Res; 2016 Aug; 36(8):4145-9. PubMed ID: 27466523
[TBL] [Abstract][Full Text] [Related]
3. Occipital anaplastic oligodendroglioma with multiple organ metastases after a short clinical course: a case report and literature review.
Li G; Zhang Z; Zhang J; Jin T; Liang H; Gong L; Cui G; Yang H; He S; Zhang Y; Gao G
Diagn Pathol; 2014 Jan; 9():17. PubMed ID: 24447608
[TBL] [Abstract][Full Text] [Related]
4. Leukemia-like onset of bone marrow metastasis from anaplastic oligodendroglioma after 17 years of dormancy: an autopsy case report.
Tanaka Y; Nobusawa S; Ikota H; Yokoo H; Hirato J; Ito H; Saito T; Ogura H; Nakazato Y
Brain Tumor Pathol; 2014 Apr; 31(2):131-6. PubMed ID: 23900511
[TBL] [Abstract][Full Text] [Related]
5. The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients.
Hacisalihoglu P; Kucukodaci Z; Gundogdu G; Bilgic B
Turk Neurosurg; 2017; 27(5):682-689. PubMed ID: 27651340
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow metastasis in anaplastic oligodendroglioma.
Sharma A; Agarwal A; Sharma MC; Anand M; Agarwal S; Raina V
Int J Clin Pract; 2003 May; 57(4):351-2. PubMed ID: 12800473
[TBL] [Abstract][Full Text] [Related]
7. Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report.
Burgy M; Chenard MP; Noël G; Bourahla K; Schott R
J Med Case Rep; 2019 Jun; 13(1):202. PubMed ID: 31248444
[TBL] [Abstract][Full Text] [Related]
8. A rare presentation of anaplastic oligodendroglioma metastatic to bone marrow, mimicking blast cells.
Liu H; Lu X; Thakral B
Br J Haematol; 2016 Aug; 174(3):344. PubMed ID: 27302043
[No Abstract] [Full Text] [Related]
9. 1p/19q chromosome deletions in metastatic oligodendroglioma.
Merrell R; Nabors LB; Perry A; Palmer CA
J Neurooncol; 2006 Nov; 80(2):203-7. PubMed ID: 16710746
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Bone Marrow Metastasis of Oligodendroglioma with IDH Mutation and 1p/19q Codeletion].
Kiko K; Suyama K; Yamamoto K; Mochida H; Oya S; Karasawa H; Watanabe S; Suzuki Y
No Shinkei Geka; 2018 Aug; 46(8):699-706. PubMed ID: 30135292
[TBL] [Abstract][Full Text] [Related]
11. Metastatic oligodendroglioma: a case report and incidence in The Netherlands.
Krijnen JL; Fleischeur RE; van Berkel M; Westenend PJ
Clin Neuropathol; 2010; 29(3):141-6. PubMed ID: 20423687
[TBL] [Abstract][Full Text] [Related]
12. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
[TBL] [Abstract][Full Text] [Related]
13. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.
Rajmohan KS; Sugur HS; Shwetha SD; Ramesh A; Thennarasu K; Pandey P; Arivazhagan A; Santosh V
J Clin Pathol; 2016 Aug; 69(8):686-94. PubMed ID: 26743027
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow infiltration by a parietal lobe grade III oligodendroglioma.
Gerrard GE; Bond MG; Jack AS
Clin Oncol (R Coll Radiol); 1995; 7(5):321-2. PubMed ID: 8580060
[TBL] [Abstract][Full Text] [Related]
16. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.
Perry A; Fuller CE; Banerjee R; Brat DJ; Scheithauer BW
Front Biosci; 2003 Jan; 8():a1-9. PubMed ID: 12456321
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic stability of oligodendrogliomas at recurrence.
Aihara K; Mukasa A; Nagae G; Nomura M; Yamamoto S; Ueda H; Tatsuno K; Shibahara J; Takahashi M; Momose T; Tanaka S; Takayanagi S; Yanagisawa S; Nejo T; Takahashi S; Omata M; Otani R; Saito K; Narita Y; Nagane M; Nishikawa R; Ueki K; Aburatani H; Saito N
Acta Neuropathol Commun; 2017 Mar; 5(1):18. PubMed ID: 28270234
[TBL] [Abstract][Full Text] [Related]
18. IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI.
Lin Y; Xing Z; She D; Yang X; Zheng Y; Xiao Z; Wang X; Cao D
Neuroradiology; 2017 Jun; 59(6):555-562. PubMed ID: 28474187
[TBL] [Abstract][Full Text] [Related]
19. Prediction of anaplastic transformation in low-grade oligodendrogliomas based on magnetic resonance spectroscopy and 1p/19q codeletion status.
Bourdillon P; Hlaihel C; Guyotat J; Guillotton L; Honnorat J; Ducray F; Cotton F
J Neurooncol; 2015 May; 122(3):529-37. PubMed ID: 25716744
[TBL] [Abstract][Full Text] [Related]
20. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]